Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Prostate Cancer / June 2005

Tip: Looking for answers? Try searching our database.

Delaying radiation for prostate cancer does not affect outcome

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
c palmer - 13 Jun 2005 09:55 GMT
13 Jun 2005

For men diagnosed with prostate cancer, there is no risk of recurrence
if external beam radiation therapy (EBRT) is delayed by several months.
A study published in the July 15, 2005 issue of CANCER
(interscience.wiley.com/cancer-newsroom), a peer-reviewed journal of the
American Cancer Society, finds delays of EBRT had no harmful impact on
clinical outcome or biochemical marker levels in low-, intermediate- and
high-risk patients.
Prostate cancer is generally a slow-developing malignancy that affects
older men. However, treatment is still important for survival and
includes surgery and radiation. The forms of available radiotherapy
include external beam radiation - 3D conformal radiation therapy
(3DCRT), intensity modulated radiation therapy, or brachytherapy.
Treatment delays of several months are quite common for men diagnosed
with prostate cancer and can cause patients concern and anxiety.
While radiation treatment delays in other cancers are associated with
increased mortality, little is known about the effect of delaying
treatment on the outcome of prostate cancer. Stephen F. Andrews, D.O.
and colleagues from the Fox Chase Cancer Center in Philadelphia reviewed
the data from almost 1500 men treated for locally confined prostate
cancer to investigate the effect of 3DCRT delay on outcome.
The investigators found that there was no difference in overall
survival, disease specific survival, the incidence of distant
metastases, and treatment failure for men who delayed 3DCRT more than
nine months. Moreover, there was no difference in outcome for men with
low-, intermediate-, and high-risk tumors who delayed treatment less
than or more 3 months.
For men with locally confined prostate cancer, "patients and physicians
can use this information to alleviate concerns and anxiety regarding
delaying treatment in order to make a well-informed treatment decision,"
conclude the authors.
Article: "Does a Delay In External Beam Radiation Therapy after Tissue
Diagnosis Affect Outcome for Men with Prostate Carcinoma?," Stephen F.
Andrews, Eric M. Horwitz, Steven J. Feigenberg, Debra F. Eisenberg,
Alexandra L. Hanlon, Robert G. Uzzo, Alan Pollack, CANCER; Published
Online: June 13, 2005 (DOI: 10.1002/cncr.2184); Print Issue Date: July
15, 2005.
John Wiley & Sons, Inc.
http://www.interscience.wiley.com

knowledge is power - growing old is mandatory - growing wise is optional    
"Many more men die with prostate cancer than of it. Growing old is
invariably fatal. Prostate cancer is only sometimes so."
http://community.webtv.net/PALMER_ENT/doc
Alan Meyer - 13 Jun 2005 22:28 GMT
> ...
> The investigators found that there was no difference in overall
[quoted text clipped - 9 lines]
> well-informed treatment decision," conclude the authors.
> ...

Didn't we see this report a few months ago?

It makes no sense at all to me.  If there is no patient for whom
treatment cannot be delayed for 3 months (or 9 months in one of
the formulations above) then, by induction, treatment is never
necessary.  Or to put it another way, treatment doesn't do any
good.

After this total absurdity, we read the following:

> For men with locally confined prostate cancer, "patients and
> physicians can use this information to alleviate concerns and
> anxiety regarding delaying treatment in order to make a
> well-informed treatment decision," conclude the authors.

This frighteningly absurd conclusion is just the ticket to enable
managed care administrators to kill their patients with
inattention while maintaining a clear conscience.

   Alan
I. P. Freely - 13 Jun 2005 23:35 GMT
Clever, accurate, but deceptive insight.
I think its fallacy -- there HAS to be one -- is that while the progosis
changes in any given three/nine months are not statistically significant,
the cumulative non-zero prognosis changes over several such periods IS often
significant. But how many HMOs would point that out?

I.P.

"Alan Meyer" <ameyer2@yahoo.com> wrote >
> It makes no sense at all to me.  If there is no patient for whom
> treatment cannot be delayed for 3 months (or 9 months in one of
[quoted text clipped - 14 lines]
>
>    Alan
Alan Meyer - 14 Jun 2005 03:49 GMT
> Clever, accurate, but deceptive insight.
> I think its fallacy -- there HAS to be one -- is that while the progosis changes in any
[quoted text clipped - 3 lines]
>
> I.P.

I don't see why there HAS to be a fallacy in my logic.  There could
very well be a fallacy in the study.

Here's an exact quote from the abstract online:

" There were no statistical differences in OS, CSS, DM, or FFBF among men whose EBRT began
< 3, 3-6, 6-9, or > 9 months after diagnosis. This was also true at the median TTT of 3.1
months. A subgroup analysis was performed in which patients were stratified into low-,
intermediate- and high-risk groups based on pretreatment PSA, Gleason score and AJCC
T-stage. FFBF, and DM were calculated above and below the median TTT of 3.1 months. In
this analysis, there was no statistically significant difference in FFBF or DM within the
risk groups."
(http://www3.interscience.wiley.com/cgi-bin/abstract/110514439/ABSTRACT)

OS = overall survival
CSS = cause specific survival
DM = distant metastasis
FFBF = freedom from biochemical failure

Notice the "> 9 months" statement.  It doesn't say how much greater.

They need to account for this - at least with a hypothesis.  How
many months _would_ be required to see a difference?

Consider this proposition: In any case of fatal prostate cancer, there is
some point in time when a distant metastasis establishes itself
and the cancer turns fatal.  Before that point, the cancer may be
cured by radiation.  After that point it cannot.

From my layman's perspective, that proposition makes sense
to me.  If it's not, why not?  If it is right, then won't that point, for at
least _some_ patients, likely fall within the time period studied?

Here's another proposition: People are diagnosed at different
stages of disease.  One guy is diagnosed in plenty of time, another
is not diagnosed until it's too late.  Some patients are going to be
diagnosed somewhere right between those two points in time -
the point on one side of which it is not too late, and on the other side
of which it is.  Some guys are going to be diagnosed one month
before that point.

I.P., your explanation of cumulative change requiring longer than
3 months - or actually longer than "> 9 months" seems to me
possible, but not plausible.  It would require that all changes in the
development of the cancer be extraordinarily slow, and that the
"point" in time when a metastasis establishes itself be longer
than 3 or 9 months.

I have a friend who had a "normal" PSA test.  He didn't know the
number.  Two years later he had another one that showed a PSA of
245.  Two months after that it was 300.  Clearly he's got metastatic
cancer.  He probably didn't have it two years before.  It's easy to
imagine there was a nine month period during which his
cancer escaped the prostate and exploded into his body.

An alternative explanation might be that his cancer was metastatic
but slow growing at the time of his normal PSA reading - in which
case he was already beyond help.  But whatever the actual case
is, it seems to me that explanation is called for.  Putting out data
like this with no explanation for why it might be accurate seems to
me to be really irresponsible.

I'm not saying that what Andrews et. al. reported is false.  It might
be true.  If so there are many possible explanations - of which the
possibility that radiation does no good - is clearly one of them.  But
I'd like to see the data checked, the math checked, the study
repeated, and the objections raised above answered, before I'm
ready to accept it.

   Alan

> "Alan Meyer" <ameyer2@yahoo.com> wrote >
>> It makes no sense at all to me.  If there is no patient for whom
[quoted text clipped - 15 lines]
>>
>>    Alan
I. P. Freely - 14 Jun 2005 06:24 GMT
> "I. P. Freely" wrote >> Clever, accurate, but deceptive insight.
>> I think its fallacy -- there HAS to be one -- is that while the progosis
[quoted text clipped - 6 lines]
> I don't see why there HAS to be a fallacy in my logic.  There could
> very well be a fallacy in the study.

There MUST be a fallacy in any path that concludes
>>> If there is no patient for whom
>>> treatment cannot be delayed for 3 months (or 9 months in one of
>>> the formulations above) then, by induction, treatment is never
>>> necessary.  Or to put it another way, treatment doesn't do any
>>> good.

Isn't it more likely that "3 months' delay does no [statistically
significant] harm" is truer than ""treatment does no good"?
The former makes perfectly good sense in any slow process; the latter
doesn't. Example: grass doesn't get noticeably taller in 24 hours, but it
sure does in a week, and mowing it sure matters. It's a matter of the ratio
of the sampling period to the growth rate.

> How > many months _would_ be required to see a difference?

How high is up? PC can take years or many decades to kill.

> Consider this proposition: In any case of fatal prostate cancer, there is
> some point in time when a distant metastasis establishes itself
> and the cancer turns fatal.  Before that point, the cancer may be
> cured by radiation.  After that point it cannot.

There's a very broad gap in your proposition which can last for many
years -- easily a decade -- in which cancer cells reside dormant and
undetectable, waiting for the right conditions to "germinate". No mets, but
untreatable because its existence and location are unknown. Then the cells'
microenvironment changes in its favor and it's off to the races and down the
tubes.

I.P.
Bill - 16 Jun 2005 15:14 GMT
Here is the operative language:
"For men with locally confined prostate cancer..."
I assume they mean at the time of treatment. So if you use that
limiting condition you could say that a delay of any length would not
matter, assuming of course that the RT is effective in knocking out all
the local PCa. As we all know, the monkey wrench in this analysis is
that you can't be sure that you have local-only disease. The danger w/
this report is that doctors will delay a local-only patient and let him
go metastatic by the time treatment begins. Personally, I don't think
there is a lot of risk in men w/ early diagnoses of a few months. Now
someone like me, w/ a first-time PSA of 30 - every day was taking a
chance on metastasis.

Bill Denton
RP 2/12/02
PSA .45
Memphis
Stephen Jordan - 16 Jun 2005 20:23 GMT
On June 16, Bill Denton wrote, in pertinent part:

> Personally, I don't think there is a lot of risk in men w/ early
> diagnoses of a few months. Now someone like me, w/ a first-time PSA
> of 30 - every day was taking a chance on metastasis.

Just a cautionary note: there's more to the markers to be monitored than
just PSA.

The other two are DRE and especially Gleason score.

As I did, a man might have a relatively low PSA (5.7) and a high Gleason
score (4+5=9 plus an initially undiscovered 4+4=8 one ). Gleason is a
measure of the aggressiveness of the tumor(s).

Regards,

Steve J

"Always do right. This will gratify some people & astonish the rest."
-- Mark Twain, "Advice to Youth"
c palmer - 14 Jun 2005 03:13 GMT
Didn't we see this report a few months ago?
It makes no sense at all to me. If there is no patient for whom
treatment cannot be delayed for 3 months (or 9 months in one of the
formulations above) then, by induction, treatment is never necessary. Or
to put it another way, treatment doesn't do any good.
        Alan

=========hi alan - i was thinking there is one very similar to this or at least
along the same lines.  for that reason, i almost didn't post it, but
thought i would, not so much to stir up anything, but to let people this
is "suppose to be the latest news"

personally, i feel this is where figures don't lie, but liars do figure.

if one does have a slow growing pca, then a few months won't hurt at
all.  but, how can one know this to be a fact in each case that they are
wanting to apply this article to?   and what about the poor guy who was
misdx'ed and now it has spread?  what do you tell him?  oops.....  sorry
about that....  well, have a nice life and don't blame me because i gave
you bum advice.

i think that articles like this are dangerous because they are open
ended.

but i post what i can find that is new because i want everyone to see
what is out there and if that article gets ripped to sheds at the
newsgroup, then we have done the lurkers a favor and gave them
information that they may have not knowledge of.

~ curtis

knowledge is power - growing old is mandatory - growing wise is optional    
"Many more men die with prostate cancer than of it. Growing old is
invariably fatal. Prostate cancer is only sometimes so."
http://community.webtv.net/PALMER_ENT/doc
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.